• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.制备、表征及体内评估 Gd-白蛋白和 Gd-树枝状聚合物作为 MRI 血管内对比增强剂。
J Inorg Biochem. 2011 May;105(5):722-7. doi: 10.1016/j.jinorgbio.2011.01.017. Epub 2011 Apr 2.
2
Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.对比衍生 DTPA 和 DOTA 钆树状聚合物配体的 MRI 性能。
Bioorg Med Chem. 2010 Aug 15;18(16):5925-31. doi: 10.1016/j.bmc.2010.06.086. Epub 2010 Jul 8.
3
Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.基于三嗪树状大分子的钆磁共振对比剂:弛豫率和体内药代动力学。
Bioconjug Chem. 2012 Nov 21;23(11):2291-9. doi: 10.1021/bc300461r. Epub 2012 Oct 22.
4
Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.纳米球蛋白大环 Mn(II)螯合物缀合物的合成与评价作为非钆(III)MRI 造影剂。
Bioconjug Chem. 2011 May 18;22(5):931-7. doi: 10.1021/bc100573t. Epub 2011 Apr 19.
5
Cyclen-based Gd complexes as MRI contrast agents: Relaxivity enhancement and ligand design.基于环烯醚萜的钆配合物作为磁共振成像造影剂:弛豫率增强与配体设计
Bioorg Med Chem. 2016 Nov 15;24(22):5663-5684. doi: 10.1016/j.bmc.2016.09.069. Epub 2016 Oct 1.
6
Gd-complexes of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-1,4,7,10-tetraacetic acid (DOTA) conjugates of tranexamates as a new class of blood-pool magnetic resonance imaging contrast agents.1,4,7,10-四氮杂环十二烷-N,N',N'',N'''-1,4,7,10-四乙酸(DOTA)与氨甲环酸的轭合物作为一类新型血池磁共振成像对比剂的钆配合物。
J Med Chem. 2011 Jan 13;54(1):143-52. doi: 10.1021/jm100966t. Epub 2010 Dec 9.
7
Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.基于聚酰胺-胺树枝状大分子的磁共振成像对比剂,通过金属预配位技术获得增强的弛豫率。
Bioconjug Chem. 2010 Jun 16;21(6):1014-7. doi: 10.1021/bc1000802.
8
Self-assembling DNA quadruplex conjugated to MRI contrast agents.与磁共振成像造影剂结合的自组装DNA四链体。
Bioconjug Chem. 2009 Feb;20(2):205-8. doi: 10.1021/bc8004182.
9
Macromolecular and dendrimer-based magnetic resonance contrast agents.基于大分子和树枝状聚合物的磁共振造影剂。
Acta Radiol. 2010 Sep;51(7):751-67. doi: 10.3109/02841851.2010.491091.
10
In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications.负载钆的沸石和钆-二乙三胺五乙酸作为磁共振成像造影剂的体外和体内比较性能研究。
J Biomed Mater Res B Appl Biomater. 2021 Aug;109(8):1105-1115. doi: 10.1002/jbm.b.34773. Epub 2020 Dec 6.

引用本文的文献

1
A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents.锰卟啉平台用于设计和合成分子及靶向 MRI 对比剂。
Int J Mol Sci. 2023 May 31;24(11):9532. doi: 10.3390/ijms24119532.
2
Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.树枝状大分子在医学应用中的安全挑战与应用策略
Pharmaceutics. 2022 Jun 17;14(6):1292. doi: 10.3390/pharmaceutics14061292.
3
Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications.用于生物成像应用的钆基造影剂的最新进展。
Nanomaterials (Basel). 2021 Sep 20;11(9):2449. doi: 10.3390/nano11092449.
4
Functionalized nanoparticles with targeted antibody to enhance imaging of breast cancer in vivo.功能化纳米颗粒靶向抗体增强乳腺癌体内成像。
J Nanobiotechnology. 2020 Sep 18;18(1):135. doi: 10.1186/s12951-020-00695-2.
5
A self-internalizing mitochondrial TSPO targeting imaging probe for fluorescence, MRI and EM.一种用于荧光、磁共振成像和电子显微镜的自内化线粒体TSPO靶向成像探针。
RSC Adv. 2014;4(18):9003-9011. doi: 10.1039/c3ra47161f. Epub 2014 Jan 3.
6
Click Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging.点击化学在磁共振成像造影剂研发中的应用
Top Magn Reson Imaging. 2016 Oct;25(5):205-213. doi: 10.1097/RMR.0000000000000099.
7
Dendrimer antibody conjugate to target and image HER-2 overexpressing cancer cells.树枝状聚合物抗体偶联物用于靶向和成像过表达HER-2的癌细胞。
Oncotarget. 2016 Jun 14;7(24):36002-36013. doi: 10.18632/oncotarget.9081.
8
Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.钆(III)与掺入脂质体中的N-烷基-N-甲基葡糖胺表面活性剂形成的配合物作为潜在的磁共振成像造影剂
Bioinorg Chem Appl. 2015;2015:942147. doi: 10.1155/2015/942147. Epub 2015 Aug 10.
9
Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging.用于近红外和磁共振成像双模态的镧系元素络合物树枝状共轭物分析
Macromolecules. 2012 Nov 27;45(22):8982-8990. doi: 10.1021/ma302206g. Epub 2012 Nov 12.
10
Design of nanovectors for therapy and imaging of cardiovascular diseases.用于心血管疾病治疗与成像的纳米载体设计
Methodist Debakey Cardiovasc J. 2012 Jan;8(1):13-7. doi: 10.14797/mdcj-8-1-13.

本文引用的文献

1
Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.对比衍生 DTPA 和 DOTA 钆树状聚合物配体的 MRI 性能。
Bioorg Med Chem. 2010 Aug 15;18(16):5925-31. doi: 10.1016/j.bmc.2010.06.086. Epub 2010 Jul 8.
2
Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.基于聚酰胺-胺树枝状大分子的磁共振成像对比剂,通过金属预配位技术获得增强的弛豫率。
Bioconjug Chem. 2010 Jun 16;21(6):1014-7. doi: 10.1021/bc1000802.
3
A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives.一种基于树枝状大分子的双功能二乙烯三胺五乙酸磁共振造影剂衍生物的制备新方法。
Bioconjug Chem. 2009 Jul;20(7):1412-8. doi: 10.1021/bc900057z.
4
Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma.使用不同造影剂观察肿瘤微血管:钆喷酸葡胺-白蛋白与B-22956/1在乳腺癌实验模型中的比较
MAGMA. 2008 May;21(3):169-76. doi: 10.1007/s10334-008-0106-6. Epub 2008 Mar 4.
5
Determinants of PF4/heparin immunogenicity.PF4/肝素免疫原性的决定因素。
Blood. 2007 Dec 15;110(13):4253-60. doi: 10.1182/blood-2007-08-105098. Epub 2007 Sep 11.
6
Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry.迈向基于树枝状大分子的磁共振成像造影剂的改进合成:新型双功能二乙烯三胺五乙酸配体及非水共轭化学
J Med Chem. 2007 Jul 12;50(14):3185-93. doi: 10.1021/jm061324m. Epub 2007 Jun 7.
7
A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice.一种基于树枝状大分子的纳米级造影剂,用于磁共振和光学荧光成像双标记,以定位小鼠前哨淋巴结。
J Magn Reson Imaging. 2007 Apr;25(4):866-71. doi: 10.1002/jmri.20852.
8
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.树枝状大分子作为用于肿瘤药物递送和诊断成像的多功能纳米器件。
Biochem Soc Trans. 2007 Feb;35(Pt 1):61-7. doi: 10.1042/BST0350061.
9
How to determine free Gd and free ligand in solution of Gd chelates. A technical note.如何测定钆螯合物溶液中的游离钆和游离配体。技术说明。
Contrast Media Mol Imaging. 2006 Sep-Oct;1(5):184-8. doi: 10.1002/cmmi.110.
10
Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin.与绿脓杆菌外毒素结合的白细胞介素13的实时、图像引导、对流增强递送
Clin Cancer Res. 2006 May 15;12(10):3145-51. doi: 10.1158/1078-0432.CCR-05-2583.

制备、表征及体内评估 Gd-白蛋白和 Gd-树枝状聚合物作为 MRI 血管内对比增强剂。

Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.

机构信息

Radioimmune & Inorganic Chemistry Section, Radiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892, United States.

出版信息

J Inorg Biochem. 2011 May;105(5):722-7. doi: 10.1016/j.jinorgbio.2011.01.017. Epub 2011 Apr 2.

DOI:10.1016/j.jinorgbio.2011.01.017
PMID:21463567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3081896/
Abstract

We report in vivo and in vitro MRI properties of six gadolinium-dendrimer and gadolinium-albumin conjugates of derivatized acyclic diethylenetriamine-N,N',N',N″, N″-pentaacetic acid (1B4M) and macrocyclic 1,4,7,10-tetraazacyclododecane-N,N',N″,N‴-tetraacetic acid (C-DOTA). The three albumin-based agents have comparable protein to chelate ratios (1:16-18) as well as molar relaxivity (8.8-10.4 mM(-1) s(-1)). The three dendrimer based agents have blood clearance half-lives ranging from 17 to 66 min while that of the three albumin-based agents are comparable to one another (40-47 min). The dynamic image obtained from use of the albumin conjugate based on the macrocycle (C-DOTA) showed a higher contrast compared to the remaining two albumin based agents. Our conclusion from all of the results is that the macrocyclic-based (DOTA) agents are more suitable than the acyclic-based (1B4M) agent for in vivo use based on their MRI properties combined with the kinetic inertness property associated with the more stable Gd(III) DOTA complex.

摘要

我们报告了六种钆树状大分子和钆白蛋白轭合物的体内和体外 MRI 性质,这些轭合物衍生自非循环二亚乙基三胺-N,N',N',N″,N″-五乙酸(1B4M)和大环 1,4,7,10-四氮杂环十二烷-N,N',N″,N‴-四乙酸(C-DOTA)。这三种基于白蛋白的试剂具有相当的蛋白与螯合物比(1:16-18)以及摩尔弛豫率(8.8-10.4 mM-1s-1)。三种基于树状大分子的试剂的血液清除半衰期范围从 17 到 66 分钟,而三种基于白蛋白的试剂的半衰期彼此相当(40-47 分钟)。使用基于大环(DOTA)的白蛋白缀合物获得的动态图像显示出比其余两种基于白蛋白的试剂更高的对比度。根据这些 MRI 性质以及与更稳定的 Gd(III)DOTA 配合物相关的动力学惰性性质,我们得出的结论是,大环基(DOTA)试剂比非环基(1B4M)试剂更适合体内使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/c6ae06f4eccd/nihms269696f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/4cba75bdb3a9/nihms269696f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/f8263c864e6c/nihms269696f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/54c42531e7c0/nihms269696f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/8b987e29c15a/nihms269696f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/63588493a20d/nihms269696f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/cae4b283613e/nihms269696f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/c6ae06f4eccd/nihms269696f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/4cba75bdb3a9/nihms269696f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/f8263c864e6c/nihms269696f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/54c42531e7c0/nihms269696f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/8b987e29c15a/nihms269696f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/63588493a20d/nihms269696f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/cae4b283613e/nihms269696f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d2b/3081896/c6ae06f4eccd/nihms269696f7.jpg